What happened: The CY2027 Medicare Physician Fee Schedule final rule published this morning in the Federal Register (91 FR 70992, Document No. 2026-22743), effective January 1, 2027. At 1,029 pages, it is one of the largest PFS final rules in recent years. CMS received approximately 43,100 public comments on the proposed rule. The final rule includes updates to the Ambulance Fee Schedule regulations (Section III.H.) alongside PFS conversion factor changes, Medicare Shared Savings Program updates, and Quality Payment Program modifications. The 2027 qualifying APM conversion factor projects a decrease of $0.62 (-1.83%) from $33.5675, while the non-qualifying APM conversion factor projects a decrease of $0.77 (-2.31%) from $33.4009.

Why it matters: For air ambulance and ground EMS operators, the PFS final rule is the single most consequential Medicare document of the year. The conversion factor declines — though smaller than some feared — mean downward pressure on rates for services tied to the PFS. More important for ambulance operators is what CMS finalized in the Ambulance Fee Schedule section, which updates regulatory framework for ground and air ambulance reimbursement geography, inflation factors, and payment policies. With GMR reporting Q3 earnings after today's close and holding its earnings call tomorrow morning, the timing could not be tighter: analysts will have actual final-rule numbers to frame their questions about CY2027 guidance. Every air medical and EMS finance team should be pulling the ambulance fee schedule details from Section III.H. today.

Source: Federal Register — 91 FR 70992 (Nov 9, 2026) | Official PDF (GovInfo)

What happened: Robinson Helicopter Company expects to certify an instrument flight rules (IFR) variant of the R66 as early as 2027. The IFR R66 will feature a Garmin G500H glass cockpit and GFC 600H autopilot, with additional hardening against HIRF and lightning, dual autopilot servos, standalone standby instruments, dual heated pitot tubes, and an additional generator and battery. The certification is being driven by the U.S. Army's Flight School Next contract, awarded to M1 Support Services in August 2026, which will use the R66 to train up to 1,500 Army pilots annually at Fort Rucker. Robinson CEO David Smith said the aircraft will provide "affordable proficiency" for instrument training.

Why it matters: Since the FAA's 2017 rotorcraft safety continuum relaxed certification standards for single-engine IFR, we've seen the Leonardo AW119, Bell 407, and Airbus H125 achieve IFR approval. The R66 will be the cheapest IFR-certified turbine helicopter on the market. For air medical operators running single-engine programs — particularly in training, private, and utility roles — this opens a lower-cost pathway to IFR capability. Smith acknowledged the IFR package will add weight, bringing the aircraft closer to a four-seat loaded configuration, but called it "absolutely a product that will add weight, that will not make it a fit for someone who's trying to fill all five seats." The real signal: IFR is no longer a premium feature reserved for $3M+ airframes. It's moving downmarket, and that's a trend the air medical training and safety communities should watch closely.

Source: Vertical Mag — November 4, 2026

What happened: Bell Textron announced delivery of the 2,000th Bell 407 on November 5, 2026, to White Saddle Air Services in British Columbia. The 407 family — including the 407GX, 407GXP, and IFR-certified 407GXi introduced in 2018 — has served operators across commercial, utility, corporate, public safety, and emergency medical services missions since entering service in the 1990s. The milestone aircraft was built at Bell's commercial center of excellence in Mirabel, Quebec.

Why it matters: The Bell 407 is the backbone of many community-based air medical fleets, including Air Methods' recent order for 15 IFR-configured 407GXis. At a time when twin-engine platforms (Bell 429, Airbus H145) dominate the HEMS headlines, the 407's 2,000-delivery milestone is a reminder that single-engine helicopters still move the majority of air medical patients worldwide. The 407GXi's IFR certification, Garmin G1000H NXi avionics, and proven reliability in high-utilization operations make it the pragmatic choice for operators balancing capability against acquisition cost — especially in rural markets where reimbursement pressure is acute. Bell's continued investment in the 407 line, alongside the 429 push, gives operators a clear single-to-twin upgrade path within the same manufacturer ecosystem.

Source: Vertical Mag / Bell Press Release — November 5, 2026

What happened: Metro Aviation unveiled a full-scale medical interior mockup for the Airbus H140 at the Air Medical Transport Conference (AMTC) in Fort Worth, Texas. The H140, introduced at Verticon 2025, sits between the H135 and H145 with approximately 20% more cabin volume, a flat floor, enlarged rear clamshell doors, and a raised Fenestron-equipped T-tail boom. Metro's interior concept features a centralized medical control console, an aft medical storage cabinet, Stryker Power-PRO stretcher compatibility, and increased mounting locations for monitors and equipment. Metro has scheduled delivery of 12 H140s beginning Q4 2028, with one in 2029, three in 2030, and seven in 2031.

Why it matters: This is the first serious medical interior design for the H140, and Metro — with decades of H135/H145 completion experience — is the right company to build it. The mockup's emphasis on crew mobility, equipment access, and modular flexibility reflects years of operator feedback. Key details: the straight rear floor edge (vs. the H135's rounded edge) allows square stretcher alignment, reducing loading risk; the centralized console eliminates leaning across patients; the aft storage cabinet turns dead space into organized capacity. Metro is treating AMTC as a design feedback session, not a product launch — the final interior will evolve based on crew input. For operators watching the H140 as a potential H135 replacement or H145 alternative, Metro's timeline (first completion likely 2029-2030) means this is a mid-term fleet planning consideration, not an immediate procurement option.

Source: Vertical Mag — October 26, 2026 | Vertical Mag — October 28, 2026

What happened: German medical technology company corpuls introduced two products to U.S. air medical providers at AMTC 2026: the corpuls auryx, an 8.6-gram in-ear sensor that measures SpO2, pulse rate, body temperature, pulse waveform, and movement via Bluetooth; and the corpuls cpr, a battery-powered mechanical chest compression device weighing 5.5 kg (12 lbs) with adjustable rates of 80-120 compressions per minute. The auryx is already certified in Europe (Class IIb) and launched internationally in August 2026. Both devices are awaiting FDA authorization before U.S. sales can begin. Chris Karageorge, corpuls' first U.S.-based employee, is leading the domestic regulatory process.

Why it matters: The auryx addresses a genuine air medical pain point: conventional fingertip pulse oximeters and temperature probes are cumbersome in confined helicopter cabins and unreliable in poor peripheral circulation. An in-ear sensor that transmits wirelessly to a tablet eliminates cable clutter and free up crew hands. The cpr device's single-arm design leaves most of the chest accessible — a meaningful advantage over frame-based competitors during in-flight resuscitation. Both products are already in use in 75+ countries, so the clinical evidence base exists. The question is FDA timeline: European med-device companies often face 12-24 month U.S. authorization delays. For U.S. operators, corpuls is worth watching — especially if the auryx can replace multiple sensors with one lightweight earbud. The 10+ hour battery life doesn't hurt either.

Source: Vertical Mag — October 29, 2026

• 1,029: Pages in the CY2027 PFS final rule (91 FR 70992), published Nov 9, 2026
• 43,100: Public comments CMS received on the CY2027 PFS proposed rule
• -1.83%: Projected qualifying APM conversion factor decrease for CY2027
• -2.31%: Projected non-qualifying APM conversion factor decrease for CY2027
• 2,000: Bell 407 helicopters delivered since the 1990s — milestone reached Nov 5, 2026
• 12: H140 helicopters on Metro Aviation order, first delivery Q4 2028
• 8.6g: Weight of the corpuls auryx in-ear vital signs sensor
• 75+: Countries where corpuls devices are already in use, pending FDA authorization

Monday, November 9 delivered exactly the convergence this briefing has been tracking for weeks. The CY2027 PFS final rule published this morning — 1,029 pages of regulatory reality that GMR will face on its earnings call tomorrow. The conversion factor declines are modest (-1.83% / -2.31%) but directional, and the ambulance fee schedule updates in Section III.H. are what EMS finance teams should be dissecting today. If GMR's management addresses the final rule directly on Tuesday's call, it'll be the first real-time market reaction to the actual numbers — not speculation, not modeling, but live commentary from the industry's largest operator.

On the aircraft side, this was a Bell-heavy news cycle: the 2,000th 407 delivery underscores the platform's staying power in an industry obsessed with twins, while the R66 IFR certification push shows IFR capability commoditizing down to lighter, cheaper airframes. The Robinson won't replace H145s or 429s in primary HEMS roles, but for training, utility, and secondary missions, it offers an intriguing cost profile. Metro's H140 interior concept is the most forward-looking story — a 2028-2031 delivery timeline means programs should be thinking about it now, especially H135 operators facing replacement decisions in the late 2020s.

Rounding out the AMTC news, corpuls’s in-ear monitor and mechanical CPR device are clever answers to cabin-space and hands-free constraints — but both await FDA authorization, so treat them as a watch item rather than an immediate buy. That’s the through-line this week: the PFS rule and Metro’s H140 timeline are long-horizon signals. The near-term catalyst is GMR’s earnings call Tuesday morning — the first live read on how the industry’s largest operator plans to absorb the new Medicare numbers. We’ll have the reaction in Wednesday’s briefing.

---

Independent. Non-biased. No affiliation with any trade association.

Written for leaders in air medical and ground ambulance transport industry.

Next briefing: Wednesday, November 11, 2026.